Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.72 USD | -4.29% |
|
-5.09% | +119.25% |
06-12 | Vera Therapeutics, Inc. Appoints Christy Oliger to the Board | CI |
05-28 | Vera Therapeutics Gets FDA Breakthrough Therapy Designation for Immunoglobulin A Nephropathy Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+119.25% | 1.84B | |
+23.13% | 46.93B | |
+37.86% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Guggenheim Initiates Vera Therapeutics With Buy Rating, $27 Price Target